#Biofire diagnostics trial#

'A simple, rapid, and accurate diagnostic test for diagnosis of meningitis and encephalitis has the potential to impact morbidity and mortality in a wide range of patients,' Leber said.

#Biofire diagnostics trial#

However, 'The publication attempts to go into more depth about the clinical trial than presented in the manufacturer's package insert,' Amy Leber, director of the clinical microbiology and immunoserology laboratory at Nationwide Children's Hospital and the corresponding author on the JCM study, told GenomeWeb in an email. The work was part of the clinical trials for the panel, which was cleared by the US Food and Drug Administration earlier this year. It was the largest clinical trial of a commercial in vitro diagnostic test for detection of multiple agents of meningitis and encephalitis in CSF specimens, according to the study. The evaluation, published in the Journal of Clinical Microbiology last week, is the result of a study of the ME Panel that was performed on 1,560 patient samples collected at 11 sites in the US over a period of eight months in 2014. It is meant for close-to-patient testing of cerebrospinal fluid specimens that are collected by a lumbar puncture from patients who are acutely ill and suspected of neurological infection, and requires only 200 microliters of CSF. The FilmArray ME Panel from BioMérieux subsidiary BioFire Diagnostics is a one-hour, sample-to-answer test for 14 different pathogens associated with infectious meningitis or encephalitis, including common bacteria, viruses, and yeasts. NEW YORK (GenomeWeb) – A multiplex panel assay that tests for pathogens responsible for meningitis and encephalitis has been evaluated in a large prospective study and found to have the potential to improve patient care.

Advances in Clinical Genomics Profiling.

Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. Plenary sessions will explore artificial intelligence-based clinical prediction models, advances in multiplex technologies, human brain organogenesis, building trust between the public and healthcare experts, and direct mass spectrometry techniques.Īt the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of the McCormick Place Convention Center in Chicago with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.ĭedicated to achieving better health through laboratory medicine, AACC brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 24-28. Today, members of the AACC Board of Directors will personally visit all 35 organizations at their booths to deliver the awards.Ībout the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo Golden honored the association's top supporters. Congratulations to this year's winners, and our sincerest thanks for enabling AACC to accomplish its goals.'ĪACC's 35 top corporate supporters were recognized during the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo at an invitation-only Corporate Recognition Reception on Monday, July 25 in Chicago.

'It is because of their support that we are able to provide laboratory medicine professionals with the resources they need to adapt to the evolving healthcare landscape. 'We at AACC are delighted to show our gratitude toward these companies,' said AACC CEO Mark J. The AACC 2022 Corporate Supporter Award recipients are as follows:Ĭlinical Laboratory News Print Advertiser of the Year These significant contributions make it possible for AACC to further its mission of better health through laboratory medicine. This year, AACC recognizes 35 different companies and organizations that generously support the association through advertising, sponsorships, and exhibiting.

CHICAGO, J/PRNewswire/ - AACC is pleased to announce the winners of its 2022 Top Corporate Supporter Awards.